ADT Inc vs ARK Genomic Revolution ETF — how do they compare? ADT Inc trades at $7.33 (market cap $5.44B), while ARK Genomic Revolution ETF trades at $44.49. The key difference: ADT Inc pays a 2.95% dividend while ARK Genomic Revolution ETF pays none, and ARK Genomic Revolution ETF is trading nearer its 52-week high, ADT Inc nearer its low. Which is the better fit depends on your goals.
| ADT | ARKG | |
|---|---|---|
Market Cap | $5.44B | — |
Sector | Industrials | Sector/Thematic |
52-Week High | $8.85 | $44.55 |
52-Week Low | $6.30 | $24.02 |
Enterprise Value | $13.13B | — |
Dividend Yield | 2.95% | — |
Signals from Pluang's Aura AI — not financial advice
ADT trades at $7.31, down 2.66% today, with a bullish technical signal from moving averages and strong earnings beats in recent quarters. The company shows solid fundamentals with a P/E of 10.35, net income margin of 11.86%, and consistent revenue growth, supported by positive analyst sentiment and institutional buying.
Outlook remains positive due to strong cash flow, dividend payments, and AI integration, but risks include high debt levels and competitive pressures. Wall Street consensus leans bullish with 47% buy ratings, suggesting potential upside if execution continues.
No Aura AI signal available yet.
Trailing returns across standard periods
ADT Inc is a provider of monitored security, interactive home and business automation, and related monitoring services in the United States and Canada. ADT offers residential, commercial, and multi-site customers a comprehensive set of burglary, video, access control, fire and smoke alarm, and medical alert solutions. It provides interactive home and business automation solutions designed to control access, react to movement, and sense carbon monoxide, flooding, changes in temperature or other environmental conditions, as well as address personal emergencies, such as injuries and medical emergencies. In addition, it offers professional monitoring of third-party devices through ADT Canopy platform. The product brands of the company are ADT and ADT Pulse, and Protection One brand.
Read more on ADT →ARKG is an actively managed ETF that invests in the genomic revolution. It focuses on companies leading in gene editing, CRISPR technology, therapeutics, and molecular diagnostics, including firms like CRISPR Therapeutics and Tempus AI.
Read more on ARKG →